Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10464 | 995 | 42.8 | 88% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MIBEFRADIL | Author keyword | 157 | 65% | 15% | 148 |
2 | T TYPE CALCIUM CHANNEL | Author keyword | 74 | 57% | 9% | 87 |
3 | T TYPE CALCIUM CHANNELS | Author keyword | 28 | 48% | 4% | 43 |
4 | T TYPE CALCIUM CHANNEL BLOCKERS | Author keyword | 27 | 92% | 1% | 11 |
5 | CAV32 | Author keyword | 27 | 63% | 3% | 27 |
6 | T TYPE CA2 CHANNEL | Author keyword | 24 | 48% | 4% | 38 |
7 | LOW VOLTAGE ACTIVATED | Author keyword | 21 | 69% | 2% | 18 |
8 | T TYPE | Author keyword | 20 | 46% | 3% | 32 |
9 | 3 4 DIHYDROQUINAZOLINE | Author keyword | 19 | 80% | 1% | 12 |
10 | EFONIDIPINE | Author keyword | 17 | 52% | 2% | 23 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MIBEFRADIL | 157 | 65% | 15% | 148 | Search MIBEFRADIL | Search MIBEFRADIL |
2 | T TYPE CALCIUM CHANNEL | 74 | 57% | 9% | 87 | Search T+TYPE+CALCIUM+CHANNEL | Search T+TYPE+CALCIUM+CHANNEL |
3 | T TYPE CALCIUM CHANNELS | 28 | 48% | 4% | 43 | Search T+TYPE+CALCIUM+CHANNELS | Search T+TYPE+CALCIUM+CHANNELS |
4 | T TYPE CALCIUM CHANNEL BLOCKERS | 27 | 92% | 1% | 11 | Search T+TYPE+CALCIUM+CHANNEL+BLOCKERS | Search T+TYPE+CALCIUM+CHANNEL+BLOCKERS |
5 | CAV32 | 27 | 63% | 3% | 27 | Search CAV32 | Search CAV32 |
6 | T TYPE CA2 CHANNEL | 24 | 48% | 4% | 38 | Search T+TYPE+CA2+CHANNEL | Search T+TYPE+CA2+CHANNEL |
7 | LOW VOLTAGE ACTIVATED | 21 | 69% | 2% | 18 | Search LOW+VOLTAGE+ACTIVATED | Search LOW+VOLTAGE+ACTIVATED |
8 | T TYPE | 20 | 46% | 3% | 32 | Search T+TYPE | Search T+TYPE |
9 | 3 4 DIHYDROQUINAZOLINE | 19 | 80% | 1% | 12 | Search 3+4+DIHYDROQUINAZOLINE | Search 3+4+DIHYDROQUINAZOLINE |
10 | EFONIDIPINE | 17 | 52% | 2% | 23 | Search EFONIDIPINE | Search EFONIDIPINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RO 40 5967 | 221 | 82% | 13% | 130 |
2 | MIBEFRADIL | 86 | 63% | 9% | 86 |
3 | CA 2 CHANNEL BLOCKER | 69 | 93% | 3% | 26 |
4 | ALPHA1G | 32 | 78% | 2% | 21 |
5 | ALPHA 1H | 29 | 67% | 3% | 26 |
6 | CAV32 | 23 | 86% | 1% | 12 |
7 | T TYPE | 21 | 21% | 9% | 89 |
8 | RAT PERIPHERAL NOCICEPTORS | 19 | 63% | 2% | 19 |
9 | ANTAGONIST RO 40 5967 | 18 | 89% | 1% | 8 |
10 | VASCULAR MUSCLE CELLS | 15 | 88% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
T-type voltage-gated calcium channels as targets for the development of novel pain therapies | 2011 | 51 | 114 | 68% |
Cardiac T-type Ca2+ channels in the heart | 2010 | 50 | 49 | 55% |
Molecular physiology of low-voltage-activated T-type calcium channels | 2003 | 805 | 437 | 30% |
T-type calcium channels blockers as new tools in cancer therapies | 2014 | 7 | 79 | 61% |
T-type calcium channels inhibitors: a patent review | 2011 | 20 | 50 | 88% |
Targeting of Ca(V)3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathy | 2014 | 7 | 29 | 48% |
Regulation of neuronal T-type calcium channels | 2009 | 50 | 72 | 64% |
Role of T-type channels in vasomotor function: team player or chameleon? | 2014 | 5 | 93 | 53% |
Modulation of low-voltage-activated T-type Ca2+ channels | 2013 | 12 | 135 | 55% |
Neuropathic pain: role for presynaptic T-type channels in nociceptive signaling | 2013 | 11 | 40 | 55% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DEP S CIRCADIAN DISORDERS | 4 | 44% | 0.7% | 7 |
2 | INTERDISCIPLINARY PROGRAM BIOTECHNOL | 4 | 46% | 0.6% | 6 |
3 | FEDERATIF RECH 3 | 3 | 60% | 0.3% | 3 |
4 | S EXCELLENCE ION CHANNEL SCI THER EUT | 2 | 36% | 0.5% | 5 |
5 | NEURONAL SIGNALING | 2 | 50% | 0.3% | 3 |
6 | QA RA PHARMACOVIGILANCE | 2 | 36% | 0.4% | 4 |
7 | SPECIAL PROCUREMENT WARD | 2 | 43% | 0.3% | 3 |
8 | CNRSUMR 5203IGF PHYSIOL | 1 | 100% | 0.2% | 2 |
9 | GENOM FONCTINSERM U661 | 1 | 50% | 0.2% | 2 |
10 | GENOM FONCTU661 | 1 | 50% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000191760 | CALCIUM SIGNALS//CALCIUM CHANNEL//PROGRAM MOL CELLULAR SYST PHYSIOL |
2 | 0.0000136902 | CILNIDIPINE//BENIDIPINE//AZELNIDIPINE |
3 | 0.0000123275 | OMEGA CONOTOXIN GVIA//OMEGA CONOTOXIN//OMEGA CONOTOXIN BINDING |
4 | 0.0000086512 | ABSENCE EPILEPSY//WAG RIJ RATS//SPIKE WAVE DISCHARGES |
5 | 0.0000069682 | CD 832//KT 362//HEART RATE DEPENDENCY |
6 | 0.0000061991 | THALAMIC RETICULAR NUCLEUS//PERIGENICULATE NUCLEUS//LATERAL GENICULATE NUCLEUS |
7 | 0.0000056436 | AMLODIPINE//DILTIAZEM CR//BESYLATE |
8 | 0.0000053387 | IMMATURE MYOCARDIUM//NEONATE MYOCARDIUM//CARDIAC MEMBRANE |
9 | 0.0000051646 | SINOATRIAL NODE//HCN CHANNELS//PACEMAKER CURRENT |
10 | 0.0000040850 | NEUROSCI REGENERAT//NAV17//NAV18 |